Vaginal Fluid and Serum CEA, CA125 and SCC in Normal Conditions and in Benign and Malignant Diseases of the Genital Tract

References

• Tholander B, Toube A, Lindgren A, et al. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis. Gynecol Oncol 1990; 39: 16–25
   PubMed Web of Science ®Google Scholar
• Werlooy H, Devos P, Janssens J, et al. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125. Gynecol Obstet Invest 1991; 32: 55–8
   PubMedGoogle Scholar
• Leminen A. Tumor markers CA125, carcinoembryonic antigen and tumor-associated trypsin inhibitor in patients with cervical adenocarcinoma. Gynecol Oncol 1990; 39: 358–63
   PubMedGoogle Scholar
• Kabawat S E, Bast R V, Welch W R, Knapp R C, Colvin R B. Immunopathologic characterization of a monoclonal antibody that recognises common surface antigens of human ovarian tumors of serous, endometrioid and clear cell types. Am J Clin Path 1983; 79: 98–104
   PubMed Web of Science ®Google Scholar
• Fuji S, Konishi I, Nambu Y, Nonogaki H, Kobayashi F, Sagawa N, Mori T, Endo K. Analysis of the levels of CA125, carcinoembryonic antigen, and CA19–9 in the cervical mucus for a detection of cervical adenocarcinoma. Cancer 1988; 62: 541–7
   PubMedGoogle Scholar
• Kearsly J, Stenzel D, Scully T, Cooke R. Cellular localization of tumor antigen (TA-4) in normal dysplastic and neoplastic squamous epithelia of the upper aerodigestive tract. Br J Cancer 1990; 61: 631–5
   PubMedGoogle Scholar
• Harlozinska A, Kula J, Stepinska B, Jelen M, Richter R, Slesak B. Cervical carcinoma antigen, carcinoembryonic antigen (CEA), and nonspecific cross-reacting antigen (NCA) in appraisal of uterine cervix smears. Am J Clin Pathol 1985; 83: 301–7
   PubMedGoogle Scholar
• Fleuren G J, Nap M, Aalders J G, Trimbos J B, de Bruijn H WA. Explanation of the limited correlation between tumor CA125 content and serum CA125 antigen levels in patients with ovarian tumors. Cancer 1987; 60: 2437–42
   PubMed Web of Science ®Google Scholar
• de Bruijn H WA, van Beeck Calkoen-Carpay T, Jager S, Duk J M, Aalders J G, Fleuren G J. The tumor marker CA125 is a constituent of normal cervical mucus. Am J Obstet Gynecol 1986; 154: 1088–91
   PubMed Web of Science ®Google Scholar
• Haga V, Sakamoto K, Egani H, Yoshimura R, Akagi M. Evaluation of serum CA125 values in healthy individuals and pregnant women. Am J Med Sci 1986; 292: 25–9
   PubMed Web of Science ®Google Scholar
• Crombach G, Scharl A, Vierbuchen M, Würz H, Bolte A. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinoma of the uterine cervix. Cancer 1989; 63: 1337–42
   PubMed Web of Science ®Google Scholar
• Benagiano G, Thomas E J. Benign proliferative disorders of the female tract: a call for a special interest group. Human Reproduction 1992; 3: 291–2
   Google Scholar
• Jacobs I, Bast R C. The CA125 tumour-associated antigen: a review of the literature. Human Reprod 1989; 4: 1–12
   PubMed Web of Science ®Google Scholar
• O'Brien J J, Hardin J W, Bannon G A, Norris J S, Quirk G. CA125 antigen in human amniotic fluid and fetal membranes. Obstet Gynecol 1986; 155: 50–5
   Google Scholar
• Lelle R J, Henkel E, Leinemann D, Goeschen K. Measurement of CEA, TPA, Neopterin, CA125, CA153 and CA19–9 in sera of pregnant women, umbilical cord blood and amniotic fluid. Gynecol Obstet Invest 1989; 27: 137–42
   PubMed Web of Science ®Google Scholar
• Sarandakou A, Kontoravdis A, Kontogeorgi Z, Rizos D, Phocas I. Expression of CEA, CA125 and SCC antigens in biological fluids associated with pregnancy. Eur J Obstet Gynecol Reprod Biol 1992; 44: 215–20
   PubMed Web of Science ®Google Scholar
• Takeshima N, Suminami Y, Takeda O, Abe H, Kato H. Origin of CA125 and SCC antigen in amniotic fluid. Asia Oceania J Obstet Gynaecol 1993; 19: 199–204
   PubMedGoogle Scholar
• Abae M, Gibson M, Chapitis J, Riddick D H, Brumsted J R. CA-125 levels in human uterine fluid. Fertil Steril 1992; 57: 531–4
   PubMed Web of Science ®Google Scholar
• von Briese V, Barten G, Strache R R, Büttner H H, Voss P. Nachweis des carcinoembryonalen antigen (CEA) in zervikovaginalspulflussigkeiten. Zent Bl Gynekol 1989; 111: 223–9
   PubMedGoogle Scholar
• Jimera P, Castilla J A, Ramirez J P, Gil T, Acebal M, Molina R, Herruzo A. Follicular fluid α-fetoprotein, carcinoembryonic antigen and CA-125 levels in relation to in vitro fertilization and gonadotropin and steroid hormone concentrations. Fertil Steril 1993; 59: 1257–60
   PubMed Web of Science ®Google Scholar
• Phocas I, Sarandakou A, Rizos D, Dimitriadou F, Mantzavinos Th, Zourlas P A. Tumour-associated antigen CEA, CA125 and SCC in serum and follicular fluid of stimulated and unstimulated cycles. Eur J Obstet Gynecol Reprod Biol 1994; 54: 1131–8
   Google Scholar
• Campbell B, De Ambrosis B. Squamous cell carcinoma antigen in patients with cutaneous disorders. J Am Acad Dermatol 1990; 22: 639–42
   PubMedGoogle Scholar
• Zeimet A G, Muller-Holzner E, Marth C R, Daxenbichler G, Dapunt O. Tumor marker CA125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle. Fertil Steril 1993; 59: 1028–35
   PubMed Web of Science ®Google Scholar
• Halila H, Huhtala M L, Haglund C, Nordling S, Stenman U H. Tumour associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA. Br J Cancer 1987; 56: 153–6
   PubMed Web of Science ®Google Scholar
• Duk J M, de Bruijn H WA, Groenier K H, et al. Cancer of the uterine cervix: Sensitivity and specificity of serum squamous cell carcinoma antigen determinations. Gynecol Oncol 1990; 39: 186–94
   PubMedGoogle Scholar
• Hoshina M, Kimura A, Shibata K, Maruo T, Moshizuki M. Immunocytological distribution of the tumor antigen TA-4: Expression during carcinogenesis and maturation of squamous epithelium of human uterine cervix. Asia Oceania J Obstet Gynecol 1986; 12: 119–26
   PubMedGoogle Scholar
• Lehtovirta P, Vinika L, Ylikorkala O. Comparison between squamous cell carcinoma-associated antigen and CA125 in patients with carcinoma of the cervix. Gynecol Oncol 1990; 37: 276–8
   PubMedGoogle Scholar
• Barbati A, Ancechi M M, Alberti P, Pomili G, Di Renzo G C, Cosmi E V. Ontogeny of CA125 antigen in pregnancy: Immunohistochemical localization in fetal membranes. Am J Obstet Gynecol 1989; 160: 514–7
   PubMed Web of Science ®Google Scholar